A Phase I in Human Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 176 in Subjects with Relapsed or Refractory Multiple Myeloma - Regional Cancer Care Associates LLC

Clinical Trials

A Phase I in Human Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 176 in Subjects with Relapsed or Refractory Multiple Myeloma

Type of Cancer
Multiple Myeloma
Locations
Hackensack
Sponsor
Amgen
Protocol Number
20150161
Cancer Diagnosis
To Learn More Call
201-510-0910